BX Swiss TOP 30 CHF

BX Swiss TOP 30 CHF handeln
1.443,96 PKT -2,19 PKT -0,15 %
finanzen.net zero
Handle Aktien, ETFs, Derivate & Kryptos ohne Ordergebühren (zzgl. Spreads) beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 12/2025)
Smartphone

WKN SL0CLV

ISIN DE000SL0CLV3


Analysen zu BX Swiss TOP 30 CHF-Werten

Datum Rating Analyst
25.01.05 Swisscom Underweight Lehman Brothers
25.01.05 UBS Buy Helvea
25.01.05 Adecco SA Accumulate Helvea
25.01.05 Holcim Accumulate Helvea
25.01.05 Novartis Outperform Goldman Sachs
26.01.05 Nestlé Outperform Credit Suisse First Boston
24.01.05 Novartis Overweight Prudential Securities
24.01.05 Richemont Outperform Goldman Sachs
24.01.05 Holcim Neutral Sarasin Research
25.01.05 Novartis Neutral Sarasin Research
24.01.05 Richemont Neutral Merrill Lynch
24.01.05 Novartis Neutral Sarasin Research
21.01.05 Logitech Accumulate Helvea
21.01.05 Roche Buy Sarasin Research
24.01.05 Lonza Reduce Sarasin Research
21.01.05 Richemont Buy Sarasin Research
24.01.05 Novartis Neutral HypoVereinsbank
21.01.05 ABB (Asea Brown Boveri) Neutral Sarasin Research
21.01.05 Richemont Accumulate Helvea
21.01.05 Novartis Kaufen Helaba Trust
24.01.05 ABB (Asea Brown Boveri) Kaufen NATIONAL-BANK
21.01.05 Richemont Buy Sarasin Research
24.01.05 Novartis Kaufen Hamburger Sparkasse
24.01.05 Straumann Outperform Credit Suisse First Boston
21.01.05 Zurich Insurance Buy Sarasin Research
21.01.05 Holcim Accumulate Helvea
21.01.05 Zurich Insurance Accumulate Helvea
20.01.05 Logitech Buy Sarasin Research
20.01.05 Holcim Halten Helaba Trust
20.01.05 Zurich Insurance Buy Sarasin Research
20.01.05 Logitech Buy Sarasin Research
20.01.05 Holcim Neutral Sarasin Research
20.01.05 Swiss Life Buy M.M. Warburg
20.01.05 UBS Buy Sarasin Research
20.01.05 Novartis Hold SEB
21.01.05 Logitech Accumulate Helvea
21.01.05 Holcim Accumulate Helvea
20.01.05 Lindt Underperform Goldman Sachs
20.01.05 Richemont Outperform Goldman Sachs
20.01.05 Novartis Akkumulieren Independent Research